Mast Therapeutics Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Tricida and Biofrontera.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | ||
Founding Date | Founding Date N/A | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cupertino, US HQ | Locations South San Francisco, US HQ | Locations Leverkusen, DE HQ |
Employees | Employees 902% increase | Employees 11914% increase | Employees 91 |
Valuation ($) | Valuation ($) 45.3 m | Valuation ($) N/A | Valuation ($) 1.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €13.2m (FY, 2025) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods N/A | Cost of goods €2.2m (FY, 2025) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit N/A | Gross profit €11.2m (FY, 2025) |
Net income | Net income ($8.3m) (FY, 2024) | Net income ($176.6m) (FY, 2021) | Net income (€6.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 157m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View companyBiofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company